skip to Main Content

Biological Breakthroughs in Pancreas Cancer

Newsfeed image, light gray text on dark gray background
Outcomes for patients with advanced pancreatic adenocarcinoma have recently begun to improve, owing to the refinement in the use of combination chemotherapy and new sequencing strategies for therapies. We are now entering an era where we are learning more about molecular differences and driving mechanisms among pancreatic cancers, with the hope of identifying personalized therapies for patient subsets.

For this Peer Exchange® discussion on recent advances and what they mean to the future of patient care Watch here . . .

Back To Top